Processing of the envelope glycoproteins of pestiviruses by Rümenapf, Tillmann et al.
Vol. 67, No. 6JOURNAL OF VIROLOGY, June 1993, p. 3288-3294
0022-538X/93/063288-07$02.00/0
Copyright X 1993, American Society for Microbiology
Processing of the Envelope Glycoproteins of Pestiviruses
TILLMANN RUMENAPF,1 GABI UNGER,2 JAMES H. STRAUSS,1 AND
HEINZ-JURGEN THIEL2*
Division ofBiology, California Institute of Technology, Pasadena, California 91125,1 and
Federal Research Centerfor Virus Diseases ofAnimals, Paul Ehrlich Strasse 28,
D-7400 Tubingen, Gernany2
Received 23 December 1992/Accepted 2 March 1993
The genomic RNA ofpestiviruses is translated into a large polyprotein that is cleaved into a number ofproteins.
The structural proteins are N terminal in this polyprotein and include three glycoproteins called EO, El, and E2
on the basis of the order in which they appear in the polyprotein. Using pulse-chase experiments, we show that
a pestiviral glycoprotein precursor, E012, is formed that is processed into EO, El, and E2 in an ordered fashion.
Processing is initiated by a nascent cleavage between the capsid and the translocated E012 followed by cleavage
at the C terminus ofE2. E012 is then rapidly cleaved to form E01 and E2. After E2 is released from the precursor,
E01 is processed into EO and El. To identify the sites of cleavage, the N termini of the glycoproteins of the
pestivirus classical swine fever virus (formerly termed hog cholera virus) were sequenced after expression in the
vaccinia virus system. The N termini are Glu-268 for EO (gp44/48), Leu-495 for El (gp33) and Arg-690 for E2
(gp55). The sequences around the cleavage sites capsid/EO and E1/E2 conform to the rules known for cellular
signal proteases, as does the sequence at the presumed C terminus of E2. The sequence upstream of the EO/El
cleavage site also shows sequence characteristics of signalase processing sites but lacks the typical hydrophobic
signal peptide; this cleavage site has characteristics in common with a site in flaviviruses that is also cleaved in a
delayed fashion. The absence of any membrane-spanning region results in the shedding of EO by infected cells,
and EO can be detected in the virus-free supernatant. Comparison of the sequences around the cleavage sites of
pestiviruses suggests a general processing scheme for the structural glycoproteins. Comparison of the pesti- and
flaviviral structural glycoproteins suggests analogies between E012 and prM-E.
Pestivirus, a genus of the family Flaviviridae (23), consists
of three distinct pathogens of farm animals, classical swine
fever virus (CSFV), bovine viral diarrhea virus (BVDV), and
border disease virus of sheep. CSFV was formerly termed
hog cholera virus and abbreviated HCV. We have reverted
to the older name CSFV for this virus in order to avoid
confusion with hepatitis C virus, which constitutes another
genus within the family Flaviviridae and is also abbreviated
HCV. Pestiviruses are enveloped, single-stranded RNA vi-
ruses that encode a single polyprotein of about 4,000 amino
acids that is processed co- and posttranslationally by both
host cell and virus-encoded proteases (17, 24, 25). The
structural proteins are located within the N-terminal third of
the polyprotein (17). Recently, we reported the structural
protein composition of CSFV (18). Purified virions consist of
p14, believed to be the nucleocapsid protein (C), and three
envelope-associated glycoproteins (E proteins), EO (gp44/
48), El (gp33), and E2 (gp55), in the order of their arrange-
ment in the polyprotein. The pestiviral capsid protein is
preceded in the polyprotein by a nonstructural protein, p23,
which is a putative protease with autoproteolytic activity
(18, 24) and which has no counterpart in flaviviruses.
Antibodies that neutralize virus infectivity are directed
against epitopes located on E2 and EO, as shown recently
(21, 22). El is believed to be buried in the viral envelope (22),
and hardly any anti-El antibodies have been described. The
glycoproteins form disulfide-linked complexes, an EO ho-
modimer with a size of 100 kDa, an El-E2 heterodimer with
a size of 75 kDa, and an E2 homodimer with a size of 100
kDa, all of which are found in infected cells as well as in
virions (18).
* Corresponding author.
On the basis of sequence analysis, processing of the
structural proteins was suggested to be mediated by host cell
signalase (17); typical hydrophobic signal sequences were
identified upstream of the putative N termini of EO and E2 by
employing von Heijne's algorithm (20). No predictions for
the cleavage that releases the N terminus of El could be
made. In the experiments reported in this paper, we deter-
mined the N termini of the three glycoproteins after expres-
sion in the vaccinia virus system and analyzed the cleavage
events involved in their production.
MATERIALS AND METHODS
Cells and viruses. CVI and BHK-21 cells were obtained
from the American Type Culture Collection (Rockville,
Md.). The pig lymphoma cell line 38A1D was kindly pro-
vided by W. Schafer (Max-Planck-Institut fur Virusforsch-
ung, Tubingen, Germany) (13). Cell lines were grown in
Dulbecco's modified Eagle medium with 10% fetal calf
serum. CSFV Alfort was from B. Liess (Veterinary School,
Hannover, Germany). The vaccinia virus-CSFV recombi-
nant VAC3.8 contains the entire region encoding the struc-
tural proteins of CSFV in the vaccinia virus thymidine
kinase gene under control of the p7.5 promoter and has been
described previously (14).
Metabolic labeling of cells and viruses. 38A1D cells (107)
were labeled for 16 h with 0.5 mCi of [3H]glucosamine
(Amersham Buchler, Braunschweig, Germany) beginning at
48 h after infection by CSFV. The labeling medium con-
tained 20 mM fructose instead of glucose. After the labeling
period, cells and tissue culture supematant were harvested
and stored at -70°C.
Preparation of labeled CSFV and virus-free supernatant.
Supernatant from infected 38A1D cells was centrifuged at
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5,400 x g for 20 min to remove cells, nuclei, and large cell
debris. After the virus had been pelleted in a Beckman
SW50.1 rotor at 40,000 rpm for 1 h, the resuspended pellet
and the virus-free supernatant were stored at -70°C.
Pulse-chase labeling of cells. CVI cells were infected with
vaccinia virus recombinant VAC3.8 (14) at a multiplicity of
infection of 10, and beginning at 16 h after infection, the cells
were labeled for 30 min with a mixture of [35S]methionine
and [35S]cysteine (Amersham Buchler) (0.5 mCi/ml) in me-
dium lacking the respective amino acids. The labeling me-
dium contained no cysteine and no methionine. The chase
was initiated by removal of the labeling medium and the
addition of Dulbecco's modified Eagle medium containing
methionine and cysteine (2.5 mM). Cells were removed 0,
15, 30, and 90 min after the beginning of the pulse and stored
at -70°C.
Radioimmunoprecipitation and SDS-PAGE. Cell and virus
extracts as well as tissue culture supernatants were prepared
for immunoprecipitation as described previously (13) and
incubated with 100 ,ul of hybridoma supematant. Precipi-
tates were formed with cross-linked Staphylococcus aureus,
analyzed by sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) (15) under reducing conditions,
and processed for fluorography by using EnHance (New
England Nuclear).
N-terminal radiosequencing. BHK-21 cells (5 x 106) were
infected with VAC3.8 at a multiplicity of infection of 10 and
labeled with 0.3 mCi of [35S]cysteine (ICN) or 0.5 mCi of
[3H]isoleucine (Amersham) from 8 to 22 h postinfection in
Dulbecco's modified Eagle medium lacking the respective
amino acid. The CSFV specific glycoproteins were purified
by immunoprecipitation with monoclonal antibodies (MAbs)
24/16 and A18. Under nonreducing conditions, MAb A18
reacts with the E1-E2 heterodimer, which permits efficient
copurification of El. The immunoprecipitated proteins were
separated on an SDS-containing 10% polyacrylamide gel and
electrotransferred to a polyvinylidene difluoride membrane
(Immobilon-P, Millipore) essentially as described previously
(6). The proteins were localized by autoradiography of the
dried membrane, the parts of the membrane containing the
proteins of interest were excised, and the proteins were
subjected to automatic Edman degradation. The amino acid
derivatives released at each cycle were collected, and the
radioactivity was assayed by liquid scintillation counting.
RESULTS
Standardized nomenclature for pestivirus glycoproteins.
Pestiviral glycoproteins have mostly been named according
to their apparent molecular masses, and thus the analogous
proteins from different strains have different names. The
apparent differences in molecular mass found among pesti-
virus strains probably result from variations in the amino
acid sequences, the degree of glycosylation, and the utiliza-
tion of different gel systems. A standardized nomenclature
for the E proteins facilitates comparisons within the Pesti-
virus genus as well as comparisons within the family Flavi-
viridae. We suggest that the E proteins be called EO, El, and
E2 to reflect their order along the genome. By using gene
order, the assignment of the glycoprotein name will ensure
that analogous proteins in different pestiviruses will always
be given the same name. The names 0, 1, and 2 were chosen
because we believe that El and E2 of pestiviruses corre-
spond to El and E2 of hepatitis C virus, respectively (see
below). In this terminology, EO represents gp44/48 of CSFV
Alfort, gp42 of CSFV Brescia, and gp48 of BVDV; El
C EO El
5 p23, p14 gp4448 gp33
51 gp42 gp3l
5# p20 p14 gp48 gp25
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FIG. 1. Suggested nomenclature and comparative representation
of the structural proteins of three pestiviruses. In most cases,
different designations have been used for the analogous proteins.
The genome localization of the putative capsid protein p14 was
shown for CSFV Alfort and BVDV (18). We propose the names C,
EO, El, and E2 according to the order of the proteins in the
polyprotein.
represents gp33 of CSFV Alfort, gp3l of CSFV Brescia, and
gp25 of BVDV; and E2 represents gp55 of CSFV Alfort,
gpSl-54 of CSFV Brescia, and gp53 ofBVDV (NADL) (Fig.
1).
Kinetics of formation of the glycoproteins. To study the
kinetics of biosynthesis of pestivirus glycoproteins, CV1
cells were infected with recombinant vaccinia virus VAC3.8,
which expresses CSFV structural proteins (14), pulse-la-
beled for 30 min with a mixture of [35S]methionine and
cysteine, and chased for various times after addition of
excess unlabeled methionine and cysteine. Cell extracts
were subjected to immunoprecipitation by using MAbs di-
rected against EO (aEO; MAb 24/16) (18) or against E2 (atE2;
MAb A18) (22), and the results are shown in Fig. 2. In
addition to the three final glycoprotein products, EO, El, and
E2, two precursors were observed. One is a polyprotein
containing the primary sequences of all three glycoproteins,
referred to as E012 (130 kDa), and reacts with either anti-
body. The second polyprotein, referred to as E01 (73 kDa),
is precipitated with MAb 24/16 (aEO) only (Fig. 2, lane 0)
and, according to its molecular mass, most likely consists of
the sequences of EO and El. The polyprotein E012 was
surprisingly stable, having a half-life of several minutes.
Because no polyprotein E12 was detectable, it appears that
the cleavage between E01 and E2 occurs prior to the
processing of E01. Thus, E012 is cleaved to form E01 and
E2, and E01 is subsequently cleaved to form EO and El.
During the course of the experiment, both EO and E2 showed
a significant reduction in their apparent molecular weights
due to trimming of the carbohydrate chains on their route
through the endoplasmic reticulum and the Golgi apparatus.
The final destination of the glycoproteins is not known
precisely, but viral assembly is believed to take place at
intracellular membranes.
The results are largely consistent with data on BVDV
proteins from Collett's group (2, 5). A low-abundance pre-
cursor with a size of about 120 kDa (gpll6) corresponding to
E012 gave rise to gp53 (E2) and gp62 (EO1); the latter was
further processed to produce gp48 (EO) and gp25 (El). In
addition, a precursor with an apparent molecular mass of 78
kDa (gp78) was described for BVDV, which was assumed to
consist of the nucleocapsid protein p14, gp48, and gp25.
However, in the CSFV system, we did not detect a precur-
sor C-EO1. The 73-kDa protein precursor identified in
VAC3.8-infected cells as E01 apparently comprises only EO
and El, because it cannot be precipitated with antibodies
against the nucleocapsid protein p14 (data not shown). E012
is also not recognized by anti-p14 antibodies (data not
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FIG. 2. Pulse-chase experiment with VAC3.8-infected cells. CVI
cells were labeled with [3S]methionine-cysteine for 30 min at 16 h
after infection by VAC3.8 at a multiplicity of infection of 10. The
chase was initiated by addition of unlabeled methionine-cysteine.
Cells were collected 0, 15, 30, and 90 min after the beginning of the
chase, and extracts were analyzed by immunoprecipitation with
MAb 24/16 (aEO) (lanes 0) or MAb A18 (aE2) (lanes 2). Precipitates
were subjected to SDS-PAGE (8% acrylamide) under reducing
conditions. Note the coprecipitation of El and E2, which is detect-
able only after a long chase. The numbers on the left refer to
molecular mass markers (Amersham) in kilodaltons.
shown). The lower-molecular-mass protein with a size of
about 64 kDa (Fig. 2) was not observed in pulse-chase
experiments with CSFV-infected cells (unpublished data)
and has not been further characterized; it may represent a
cross-reacting vaccinia virus protein. The reason for the
observed differences between the BVDV and CSFV systems
remains to be determined.
The experiment shown in Fig. 2 also confirms the fact that
El and E2 form a stable complex that can be precipitated
with antibodies directed against E2 (22). Note that this
complex forms slowly; only after a 90-min chase are signif-
icant amounts of the complex demonstrable.
Identification of the N termini of the glycoproteins. We
wished to identify the cleavage sites used to process the
glycoproteins in order to more fully characterize these
proteins and because the nature of these cleavage sites might
define the proteases involved in the processing of pestivirus
E proteins. N-terminal sequencing of CSFV glycoproteins
was conducted with radiolabeled CSFV E proteins which
were produced in BHK-21 cells by recombinant vaccinia
virus VAC3.8 (14). The N termini determined were Glu-268
for EO, Leu-495 for El, and Arg-690 for E2 (Fig. 3a through
c). N-terminal sequencing of purified unlabeled CSFV pro-
teins yielded identical results, which confirms the authentic
processing of VAC3.8-expressed proteins (18a).
Properties of the E proteins. The N terminus of EO was
found to be Glu-268 (Fig. 3a). With an assumed C terminus
at Ala-494, EO consists of 227 amino acids with a calculated
molecular mass of 25.7 kDa. EO is heavily glycosylated,
suggesting that all nine possible N-glycosylation sites are
occupied. EO does not appear to possess a membrane
to o1%
0~~~~~~~~~~~~~~~~~~~0
100
0 0
RLACKEDYRYAISSTNEIGLLGAE
c 2000 300
C I I
1000 A 1
0 ,
0 10 20
FIG. 3. Determination of the N termini of CSFV glycoproteins
EO (a), El (b), and E2 (c) from VAC3.8-infected cells. The amino
acid sequence at the top of each panel is a sequence from the CSFV
polyprotein beginning with the N-terminal amino acid determined in
this study. Radiosequencing results are shown in the graphs in each
panel. Open circles represent the radioactivity (in counts per
minute) released during each cycle for [3H]Ile-labeled protein, and
solid squares represent [35S]Cys-labeled protein (in counts per
minute).
anchor, and after its release from EO1 presumably remains
associated with the budding virus only through noncovalent
associations with the other glycoproteins. In order to test for
the stability of the association of EO with the other glyco-
proteins, the culture medium covering CSFV-infected cells
was collected, virus was purified from it, and the purified
virus preparation and the virus-free medium were examined
for the presence of glycoproteins by immunoprecipitation.
Figure 4 shows an immunoprecipitation with MAb 24/16
(aEO) and MAb A18 (aE2), in which a lysate from CSFV-
J. VIROL.
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FIG. 4. Secretion of EO into the medium. 38A1D cells were
labeled with [3H]glucosamine for 16 h, beginning at 48 h after
infection by CSFV. Cell lysates (lanes 1 and 3), virus-free superna-
tant (lanes 2 and 4), and pelleted virions (lanes 5 and 6) were
subjected to immunoprecipitation with MAb 24/16 (aEO) or MAb
A18 (aE2) as indicated in the figure. EO is clearly detectable as a
soluble protein in the virus-free medium. The precipitates were
subjected to SDS-PAGE (8% acrylamide) under reducing condi-
tions. The numbers on the left refer to molecular mass markers
(Amersham) in kilodaltons.
infected cells (Fig. 4, lanes 1 and 3) is compared with purified
virions (lanes 5 and 6) and virion-depleted medium (lanes 2
and 4) from the same experiment. Significant amounts of
soluble EO were present in the virus-free medium as well as
in the cell lysates and in purified virions. In contrast, E2 was
only present in the cell lysate and in virions. The shedding of
EO into the medium is consistent with the absence of a
membrane anchor in EO. Note the increase in the molecular
masses of E0, El, and E2 present in virions (Fig. 4, lanes 5
and 6) and virus-depleted supernatant (Fig. 4, lane 2) com-
pared with those from cells. Most likely, changes in the
carbohydrate composition during transit through the Golgi
apparatus account for this shift. We have also found that
soluble EO is present in large amounts in the supematant of
VAC3.8-infected cells (data not shown).
Leu-495 (Fig. 3b) forms the N terminus of El. If the
protein extends to a C-terminal Gly-689, the size of El is 195
amino acids and its unmodified mass is 21.8 kDa. There are
three sites for N glycosylation, all of which are probably
occupied in CSFV Alfort. Two quite hydrophobic sequences
in the protein probably serve as membrane anchors. The first
anchor covers the sequence Leu-548 to Pro-579, and the
second one covers Thr-659 to Gly-689. Presumably, the first
anchor functions as a stop-transfer signal for El and the
second anchor functions as a signal peptide for the translo-
cation of E2, analogous to the situation in other enveloped
viruses, such as those of the families Togaviridae and
Flaviviridae, that also contain more than one membrane-
spanning envelope protein.
The N terminus of E2 is formed by Arg-690 (Fig. 3c). The
C terminus of E2 is not defined precisely, but functional
studies with C-terminal truncations suggest that the C ter-
minus is located around amino acid 1060 (12a, 19). From this
estimate, E2 consists of about 370 amino acids (calculated
molecular mass, 41 kDa), which conforms to previous stud-
ies on the size of the nonglycosylated E2 of BVDV (2). This
would also indicate that the C-terminal domain of E2 con-
tains at least 40 hydrophobic amino acids which probably
form one or more membrane-spanning anchors.
Eo
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FIG. 5. Alignment of the amino acid sequences of CSFV Alfort
and Brescia and BVDV NADL in the region of the cleavage sites
determined for CSFV Alfort. The arrows indicate the start of each
protein, and the numbers give the positions of the N-terminal amino
acid in the polyproteins of CSFV or BVDV.
Characteristics of the cleavage sites. The sequence sur-
rounding the E1/E2 cleavage site containing Arg-690 con-
forms to a typical site cleaved by signal peptidase. There is
a 16-amino-acid membrane-spanning hydrophobic region
followed by residues defined by the -1, -3 rule (20). In
computer-aided analysis (7), this processing site was pre-
dicted with a score of 8.8, which indicates there is a high
probability that the site is in fact cleaved by signal peptidase.
In view of the finding that E012 appears in VAC3.8-infected
cells, cleavage at this site appears to be slightly delayed,
rather than instantaneous as is the case with most signal
peptidase cleavages.
In contrast to the situation with E2, the N terminus of El
was not predicted correctly. The sequence upstream of
Leu-495 contains the residues required by the -1, -3 rule
for signalase cleavage but lacks the hydrophobic domain
which commonly defines a signal peptide. It could represent
an incomplete signal sequence, which accounts for the
atypical, delayed signalase cleavage, or the sequence could
be cleaved by a different enzyme, possibly a Golgi appara-
tus-associated protease.
The cleavage site Ala-267/Glu-268 that generates the N
terminus of EO is preceded by a hydrophobic sequence of 18
amino acids and resembles a typical signal peptidase cleav-
age site (20). Cleavage at this site appears to be analogous to
the cleavage separating the flavivirus capsid and prM pro-
teins, which is also believed to be catalyzed by signalase
(11).
Pestiviruses show a high degree of sequence conservation
among the sequenced strains. Figure 5 illustrates the peptide
sequences of CSFV Alfort (9) and Brescia (10) and BVDV
NADL (3) in the region of the processing sites determined by
us for CSFV Alfort. The overall similarity in these regions
suggests that processing of the E proteins of the other
pestiviruses occurs at the homologous sites. Interestingly,
the highest degree of conservation is found around the EO/El
cleavage site, while the hydrophobic signal peptides up-
stream of EO and E2 exhibit more divergence.
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FIG. 6. Proposed processing scheme of pestiviral E proteins. Processing is initiated by the translocation of the signal peptide upstream of
EO. Scissors indicate signalase cleavage; the solid wedge indicates cleavage by an unknown protease which cleaves the E0/E1 site. El bears
two putative membrane-spanning regions, the first of which acts as a stop-transfer signal for El and the second of which functions as a
translocation signal for E2. Preliminary studies indicate that the C terminus of E2 includes about 30 hydrophobic amino acids which could
function as a stop-transfer signal for E2 and as a translocation signal for the downstream protein (12a, 19). The translation product
downstream of E2 is hypothetical and has not yet been identified; Collett suggested that the N terminus of the nonstructural p125 was near
amino acid 1130 (4), which would leave space for a 70-amino-acid peptide. The character of this sequence is hydrophobic, which probably
renders the protein membrane associated. ER, endoplasmic reticulum.
DISCUSSION
Synthesis and processing of the glycoproteins. Three cleav-
age events in the formation of the glycoproteins, namely
capsid/EO, El/E2, and the cleavage at the C terminus of E2,
are most likely mediated by host cell signalase. The compo-
sition of the sequences upstream of these cleavage sites
conforms to the rules proposed by von Heijne (20). The -1,
-3 rule postulates a small amino acid at position -1, usually
Ala or Gly (50% and 24%, respectively). At the -3 position,
the rule excludes aromatic, charged, or large polar residues.
Here, Ala is most abundant (47%), followed by Val, Ser,
Cys, and Thr. The -1 position of the CSFV (Alfort) E
protein cleavage sites is Ala or Gly, and from amino acid
sequence homology, Ala or Gly is also expected to be at the
-1 position for the two other pestiviruses whose sequences
are known. The -3 position is occupied in these sequences
by Ala, Val, or Thr (Fig. 5).
We can now suggest a processing scheme for the produc-
tion of pestiviral glycoproteins (Fig. 6). The first step is the
translocation of the internal signal peptide downstream of
the capsid protein. The cleavage between the capsid and the
nascent E012 occurs rapidly upon translocation and is ef-
fected by signalase. Whether the signal sequence represents
an integral part of the capsid protein, rendering it an "an-
chored core" as described for flaviviruses (11), is currently
under investigation. Transfer of the nascent E012 is inter-
rupted by two hydrophobic stretches at the end of El-the
first acts as a stop-transfer signal, and the second acts as a
signal sequence to begin transfer of E2. The hydrophobic
sequences also form an anchor for El. Translocation of E2
then follows until interrupted by a set of stop/start transfer
signals at the putative C terminus which anchors E2 and may
also direct translocation of the next protein in the polypro-
tein. The cleavage between E012 and the downstream trans-
lation product apparently occurs rapidly, because there is no
evidence for a larger precursor (Fig. 2). The internal pro-
cessing of the E012 precursor is initiated by the release of
E2. E012 is readily detectable in VAC3.8-infected cells (Fig.
2), and the time required for cleavage at the El/E2 site
appears to be slightly delayed, which is surprising because
signalase cleavage is normally considered to occur instantly
upon translocation. The release of E2 then allows cleavage
at the EO/El site. It is unclear whether this hierarchical
cleavage pattern occurs because EO1 serves as a substrate
for signalase only after the release of E2 permits a particular
structure to be formed or whether E01 is transported to a
different compartment, such as the Golgi apparatus, where it
is processed by an as yet undefined protease. The EO/El
cleavage has characteristics in common with the cleavage at
the flavivirus NS1/NS2A site. The cleavage occurs down-
stream of a sequence similar to those commonly employed
by signalase but lacks an upstream hydrophobic domain and
is delayed. The flavivirus cleavage has been hypothesized to
be effected by an uncharacterized protease in the Golgi
apparatus (12). The pestivirus cleavage site does not have
the consensus sequence of the flavivirus site, however, and
further study is required to determine the enzyme responsi-
ble for cleavage.
It is interesting that the formation of a stable El-E2
heterodimer occurs late, apparently after trimming of carbo-
hydrate chains and thus after the E proteins have left the
endoplasmic reticulum (Fig. 2). This could indicate that El
and E2 associate only late, possibly at the location of virus
assembly. Alternatively, El and E2 could form an unstable
complex early which is later stabilized by formation of
disulfide bonds or by formation of stronger noncovalent
bonds. The glycoproteins present in the virion are exclu-
sively hetero- or homodimeric; thus, dimerization could be
important in the assembly of the virus. While El and E2 are
almost certainly anchored in the lipid bilayer of the enve-
lope, the mechanism by which EO is associated with the
virion remains unclear. Noncovalent interactions with the
El-E2 dimer or hydrophobic interactions with the lipid
bilayer, which could conceivably include covalently linked
lipids or glycolipids, could link EO to the envelope. The fact
that considerable amounts of EO are shed into the medium
indicates that the association of EO with the envelope is more
tenuous than is the association of El and E2.
Similarities of pestivirus, flavivirus, and hepatitis C virus
glycoproteins. The properties of the E proteins of pestivi-
ruses show analogies to those of other members of the family
Flaviviridae. In the genus Flavivirus, there are two envelope
proteins, prM and E, positioned immediately downstream of
the capsid protein in the polyprotein precursor. The capsid
protein is followed by an internal signal peptide that directs
translocation of prM and results in an anchored core after
signalase cleavage generates the N terminus of prM. Follow-
ing prM is a stop/start transfer sequence analogous to that
between pestivirus E01 and E2 which directs translocation
of E and anchors prM after signalase cleavage generates the
J. VIROL.
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N terminus of E. prM is later processed to M, which is C
terminal in prM, and an N-terminal fragment, often referred
to as pr, which lacks an anchor and is released into the
medium; this cleavage occurs late, possibly in conjunction
with virus maturation. While only M and E are considered
structural proteins, prM is also detectable in "immature"
virions as unprocessed prM (11). The flaviviral E protein
shares functional similarity with E2 as the major antigen, and
in its hydrophobicity M is reminiscent of El. We suggest
therefore that pestivirus E01 is analogous to prM of flavivi-
ruses and that pestivirus E2 is analogous to flavivirus E.
Although the cleavages of EO1 and prM occur late and may
be associated with virus maturation, different enzymes are
responsible for the cleavages. Cleavage of prM occurs
downstream of a dibasic sequence and is believed to be
effected by a cathepsin-like protease present in the Golgi
apparatus (1). We speculate that a Golgi-associated protease
may also be responsible for the cleavage of EO1, but the
enzyme cleaves after amino acids with short side chains
similar to those preferred by signalase. However, there are
precedents for atypical signalase cleavages, and it remains
possible that signalase is responsible for the EO1 cleavage.
Following E2 in pestiviruses is a very hydrophobic protein
reminiscent of the NS2A-NS2B complex of flaviviruses. In
our model, then, there is no equivalent to flavivirus NS1 in
pestiviruses. NS1 is a glycoprotein but is not incorporated
into the virion. It is present on the cell surface and elicits a
cytotoxic immune response. It is possible that flaviviral NS1
initially was an envelope glycoprotein that lost its function as
a structural protein but remained indispensable for virus
assembly or for some other required function.
The putative envelope proteins of hepatitis C virus, pres-
ently called El and E2/NS1, were recently identified by
using different expression systems (8, 16). Initially termed E
and NS1 on the basis of comparisons of the hydrophobicity
plots of hepatitis C virus and of flavivirus proteins, both
glycoproteins show features of envelope proteins. E2 of
hepatitis C virus is very likely analogous to the pestiviral E2,
and El of hepatitis C virus may be analogous to pestiviral
El. There appears to be no equivalent of pestiviral EO in
hepatitis C virus. In this model, hepatitis C virus also has no
equivalent of flaviviral NS1. In the absence of amino acid
sequence homology, it is not possible to determine which of
the envelope proteins may have been derived from the same
ancestral protein or to be certain whether the proteins El
and E2 are functionally equivalent to flaviviral M and E.
Collett et al. have suggested, for example, that E2 of the
pestiviruses is equivalent to or arose from NS1 (4). Struc-
tural studies to resolve these issues will be very interesting.
While pestiviruses, flaviviruses, and hepatitis C virus
undoubtedly share a common heredity, they show consider-
able divergence in their structural proteins, probably reflect-
ing adaptation for replication in different host tissues and in
response to immunological pressure. Divergence may have
arisen in part because of a general permissiveness for the
introduction of point mutations in this region, but it is also
probable that recombinational events led to some of the
apparent differences in the envelope proteins from the dif-
ferent genera of the family Flaviviridae.
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